FDA Commissioner: Insurers Need To Support Studies In Accelerated Drug Approval Pathway
The Food and Drug Administration’s Dr. Robert Califf called on insurers Thursday to help ensure that studies on new drugs in the accelerated approval pathway are still completed.
“I don’t think it’s just a matter…